Patent Assignment
Reel/Frame 057566/0672
Assignment of Assignor's Interest
Recorded: 2021-09-22
Pages: 4
Assignee
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Cancer Combination Therapies Utilizing a Nicotinamide Phosphoribosyltransferase Inhibitor in Combination with a Nicotinamide Adenine Dinucleotide Salvage Pathway Precursor
Application:
17/441,599 →
Publication:
US 2022/0125814
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Jun 23, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060439/0279 →
Corrective Assignment to Correct the Patent Application Number 63/242,906 Previously Recorded on Reel 060439 Frame 0279. Assignor(S) Hereby Confirms the Merger and Change of Name.
Nov 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061847/0594 →
Confirmatory License
Dec 13, 2023
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065968/0293 →
Merger and Change of Name
May 18, 2026
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 074681/0643 →